drugset / Trial / NCT00103818

An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)

NCT00103818

Phase 3 Completed 900 enrolled H. Lundbeck A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and effectiveness of MK0928 for insomnia (a sleep disorder).

Timeline

Start
2005-02
Primary completion
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject gaboxadol Small molecule 10 mg
Subject gaboxadol Small molecule 15 mg

Indications